These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 11650687)
1. The impact of biotechnology on corporate law and regulation. Green HP Technol Soc; 1983; 5(2):87-94. PubMed ID: 11650687 [No Abstract] [Full Text] [Related]
2. State biotechnology oversight: the juncture of technology, law, and public policy. Vito CC Maine Law Rev; 1993; 45(2):329-83. PubMed ID: 11652701 [No Abstract] [Full Text] [Related]
3. Recombinant DNA: triumph or Trojan horse? Holtzman E Man Med; 1977; 2(2):83-103, W7. PubMed ID: 12083131 [No Abstract] [Full Text] [Related]
4. Recombinant DNA and the law: review of some general legal considerations. Korwek EL Gene; 1981; 15():1-5. PubMed ID: 11658461 [No Abstract] [Full Text] [Related]
5. The regulation of recombinant DNA research: the alternative of local control. Rosenblatt DP Boston Coll Environ Aff Law Rev; 1982; 10(1):37-78. PubMed ID: 11649694 [No Abstract] [Full Text] [Related]
6. Biotechnology and culture: the impact of public debates on government regulation in the United States and Denmark. Baark E; Jamison A Technol Soc; 1990; 12(1):27-44. PubMed ID: 11650912 [No Abstract] [Full Text] [Related]
7. Recombinant DNA and the regulation of biotechnology: reflections on the Asilomar Conference, ten years after. Barkstrom JE Akron Law Rev; 1985; 19(1):81-126. PubMed ID: 11650740 [No Abstract] [Full Text] [Related]
8. Recombinant DNA: a case study in regulation of scientific research. Chalfant JC; Hartmann ME; Blakeboro A Ecol Law Q; 1979; 8(1):55-129. PubMed ID: 11665069 [No Abstract] [Full Text] [Related]
9. Proposal for a coordinated framework for regulation of biotechnology. U.S. Office of Science and Technology Policy Fed Regist; 1984 Dec; 49(252):50856-907. PubMed ID: 11655658 [No Abstract] [Full Text] [Related]
10. Corporate responsibility for recombinant DNA activities. Berger BA Univ Toledo Law Rev; 1981; 12(4):913-24. PubMed ID: 11649592 [No Abstract] [Full Text] [Related]
11. The double helix of self-interest. Simring FR Sciences (New York); 1977; 17(3):10-13+. PubMed ID: 11661478 [No Abstract] [Full Text] [Related]
12. Recombinant DNA and technology assessment. Georgetown Law J; 1977; 11(4):785-878. PubMed ID: 11664859 [No Abstract] [Full Text] [Related]
13. Biotechnology and the lawmakers. Schmitt H Technol Soc; 1983; 5(1):5-14. PubMed ID: 11650685 [No Abstract] [Full Text] [Related]
14. Biotech's stalled revolution. Schneider K N Y Times Mag; 1986 Nov; ():42-44, 47-48+. PubMed ID: 11649783 [No Abstract] [Full Text] [Related]
15. Recombinant DNA research guidelines: draft environmental impact statement. U.S. National Institutes of Health Fed Regist; 1976 Sep; 41(176):38426-83. PubMed ID: 11663693 [No Abstract] [Full Text] [Related]
16. Genetic engineering and related biotechnologies: scientific progress and public policy. Perpich JG Technol Soc; 1983; 5(1):27-49. PubMed ID: 11650684 [No Abstract] [Full Text] [Related]
17. Institutional biosafety committees and the inadequacies of risk regulation. Bereano PL Sci Technol Human Values; 1984; 9(4):16-34. PubMed ID: 11649608 [No Abstract] [Full Text] [Related]
18. Ethical and legal issues in patenting new animal life. Dresser R Jurimetrics; 1988; 28(4):399-435. PubMed ID: 11652544 [No Abstract] [Full Text] [Related]
19. Coordinated framework for regulation of biotechnology; announcement of policy; notice for public comment. U.S. Office of Science and Technology Policy Fed Regist; 1986 Jun; 51(123):23302-50. PubMed ID: 11655807 [No Abstract] [Full Text] [Related]
20. Coordinated framework for regulation of biotechnology; establishment of the Biotechnology Science Coordinating Committee; notice. U.S. Office of Science and Technology Policy Fed Regist; 1985 Nov; 50(220):47174-95. PubMed ID: 11655733 [No Abstract] [Full Text] [Related] [Next] [New Search]